BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients

SARS-CoV-2 vaccination is the standard of care for the prevention of COVID-19 disease. Although vaccination triggers both humoral and cellular immune response, COVID-19 vaccination efficacy is currently evaluated by measuring antibodies only, whereas adaptative cellular immunity is unexplored. Our a...

Descripción completa

Detalles Bibliográficos
Autores principales: La Civita, Evelina, Zannella, Carla, Brusa, Stefano, Romano, Paolo, Schettino, Elisa, Salemi, Fabrizio, Carrano, Rosa, Gentile, Luca, Punziano, Alessandra, Lagnese, Gianluca, Spadaro, Giuseppe, Franci, Gianluigi, Galdiero, Massimiliano, Terracciano, Daniela, Portella, Giuseppe, Loffredo, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459971/
https://www.ncbi.nlm.nih.gov/pubmed/37632002
http://dx.doi.org/10.3390/v15081659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459971/
https://www.ncbi.nlm.nih.gov/pubmed/37632002
http://dx.doi.org/10.3390/v15081659

Ejemplares similares